Dermatology adhesive patch

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a top plan view of a dermatology adhesive patch, showing my new design; and,

FIG. 2 is a bottom plan view of the dermatology adhesive patch.

Any part of the dermatology adhesive patch not shown forms no part of the design.

Claims

The ornamental design for a dermatology adhesive patch, as shown and described.

Referenced Cited
U.S. Patent Documents
3731683 May 1973 Zaffaroni
4122947 October 31, 1978 Falla
5160315 November 3, 1992 Heinecke
5190049 March 2, 1993 Briggs et al.
D355489 February 14, 1995 Almond
5438984 August 8, 1995 Schoendorfer
5921396 July 13, 1999 Brown, Jr.
5989815 November 23, 1999 Skolnick et al.
5994149 November 30, 1999 Robinson et al.
6106732 August 22, 2000 Johnston et al.
6176836 January 23, 2001 Trudil et al.
6203987 March 20, 2001 Friend et al.
6300140 October 9, 2001 Robinson et al.
6355439 March 12, 2002 Chung et al.
6447463 September 10, 2002 Borkowski
D480811 October 14, 2003 Horhota
D481131 October 21, 2003 Saim
6720145 April 13, 2004 Rheins et al.
6949338 September 27, 2005 Rheins et al.
D512509 December 6, 2005 Yamasoto
D513639 January 17, 2006 Saim
D516727 March 7, 2006 Neri
7129389 October 31, 2006 Watson
7183057 February 27, 2007 Benson
7247426 July 24, 2007 Yakhini et al.
7267951 September 11, 2007 Alani et al.
7297480 November 20, 2007 Vogt
D576282 September 2, 2008 Yanaki
7662558 February 16, 2010 Liew
D618357 June 22, 2010 Navies
D620123 July 20, 2010 Igwebuike
7771950 August 10, 2010 Wohlgemuth et al.
7919246 April 5, 2011 Lai et al.
7921999 April 12, 2011 Kimball
7972788 July 5, 2011 Miyata et al.
7989165 August 2, 2011 Benson
8067173 November 29, 2011 Liew
D673166 December 25, 2012 Mori et al.
8492102 July 23, 2013 Kashani-Sabet et al.
D688377 August 20, 2013 Heinecke
8541170 September 24, 2013 Kennedy et al.
D692149 October 22, 2013 Uematsu
D692152 October 22, 2013 Inoo
D704343 May 6, 2014 Inoo et al.
8938684 January 20, 2015 Guertler et al.
9057109 June 16, 2015 Chang
D738514 September 8, 2015 Tagami et al.
D745973 December 22, 2015 Russo
D747455 January 12, 2016 Uematsu
D759828 June 21, 2016 Riedle
D764580 August 23, 2016 Solomon et al.
D764581 August 23, 2016 Solomon et al.
D773060 November 29, 2016 Narvekar
D785189 April 25, 2017 Dettmar
D786282 May 9, 2017 Donnelly
D787689 May 23, 2017 Roberts
D788142 May 30, 2017 Burke
D808026 January 16, 2018 Moore
D816697 May 1, 2018 Ledford et al.
D816699 May 1, 2018 Ledford et al.
D816700 May 1, 2018 Bayer et al.
D857212 August 20, 2019 Sugaya et al.
10407729 September 10, 2019 Chang
D865056 October 29, 2019 Martin
10631983 April 28, 2020 Christianson
10709428 July 14, 2020 Palmer et al.
10781200 September 22, 2020 Mcdonald et al.
D899606 October 20, 2020 Kang
D899607 October 20, 2020 Ryu
D929596 August 31, 2021 Yu
D944284 February 22, 2022 Metzger et al.
D944286 February 22, 2022 Sanchez et al.
D946017 March 15, 2022 Courtney et al.
11307876 April 19, 2022 Leonard, II et al.
D954273 June 7, 2022 Wallace
D966299 October 11, 2022 Dobak, III et al.
D966300 October 11, 2022 Dobak, III et al.
11578373 February 14, 2023 Dobak, III et al.
11643689 May 9, 2023 Dobak, III et al.
D988399 June 6, 2023 Dobak, III et al.
D989861 June 20, 2023 Dobak, III et al.
D1012296 January 23, 2024 Ehouarn
D1012297 January 23, 2024 Ehouarn
D1023321 April 16, 2024 Kenney
D1048417 October 22, 2024 Wassink
20010024783 September 27, 2001 Iversen
20020110824 August 15, 2002 Rheins et al.
20020115086 August 22, 2002 Rheins et al.
20020119471 August 29, 2002 Rheins et al.
20020127573 September 12, 2002 Rheins et al.
20020150918 October 17, 2002 Rheins et al.
20030045810 March 6, 2003 Borkowski
20030098580 May 29, 2003 Christy
20030108896 June 12, 2003 Vogt
20030113906 June 19, 2003 Sangha et al.
20030152923 August 14, 2003 Yakhini et al.
20030171328 September 11, 2003 Iversen
20030175736 September 18, 2003 Chinnaiyan et al.
20030228617 December 11, 2003 Aune et al.
20050221334 October 6, 2005 Benson
20060019256 January 26, 2006 Clarke et al.
20060040335 February 23, 2006 Butt et al.
20060153816 July 13, 2006 Brown et al.
20060242554 October 26, 2006 Gerace et al.
20070082347 April 12, 2007 Lanchbury et al.
20070087323 April 19, 2007 Armitage et al.
20070099209 May 3, 2007 Clarke et al.
20070243537 October 18, 2007 Tuck et al.
20070281314 December 6, 2007 Benson
20080009779 January 10, 2008 Fabo
20080032293 February 7, 2008 Szabo et al.
20080131902 June 5, 2008 Maor et al.
20080138819 June 12, 2008 Vogt
20080200870 August 21, 2008 Palmroos et al.
20080274908 November 6, 2008 Chang
20090010997 January 8, 2009 Haley
20090082265 March 26, 2009 Bartel et al.
20090246768 October 1, 2009 Sawalha et al.
20090263792 October 22, 2009 Miyata et al.
20090298060 December 3, 2009 Lal et al.
20090299640 December 3, 2009 Ellis et al.
20100086501 April 8, 2010 Chang et al.
20100105102 April 29, 2010 Hanes et al.
20100239648 September 23, 2010 Smith
20100267033 October 21, 2010 Abbas et al.
20100279877 November 4, 2010 Vogt
20110059113 March 10, 2011 Celebi
20110158953 June 30, 2011 Scott
20110159496 June 30, 2011 Kashani-Sabet et al.
20110160080 June 30, 2011 Chang
20110262464 October 27, 2011 Chin et al.
20110287034 November 24, 2011 Frank et al.
20120065086 March 15, 2012 Benson
20120071343 March 22, 2012 Ma et al.
20120201750 August 9, 2012 Ryu
20130060184 March 7, 2013 Rea
20130079423 March 28, 2013 Abkevich et al.
20130143747 June 6, 2013 Gutin et al.
20130244256 September 19, 2013 Clarke et al.
20130296185 November 7, 2013 Benson
20130302242 November 14, 2013 Stone et al.
20130344481 December 26, 2013 Kashani et al.
20140045915 February 13, 2014 Skog et al.
20140154684 June 5, 2014 Chang
20140206574 July 24, 2014 Chapman et al.
20140323331 October 30, 2014 Chang et al.
20150005184 January 1, 2015 Alsobrook et al.
20150259739 September 17, 2015 Chang et al.
20150361500 December 17, 2015 Ang et al.
20160024595 January 28, 2016 Alsobrook, II
20180110500 April 26, 2018 Palmer
20190290799 September 26, 2019 Arshi
20190367994 December 5, 2019 Chang
20190369119 December 5, 2019 Zhuang et al.
20200149115 May 14, 2020 Dobak et al.
20200289099 September 17, 2020 Palmer et al.
20200308649 October 1, 2020 Dobak et al.
20200308657 October 1, 2020 Dobak et al.
20200319205 October 8, 2020 Dobak et al.
20200383665 December 10, 2020 Palmer et al.
20200383835 December 10, 2020 Barr
20200407800 December 31, 2020 Dobak et al.
20210196247 July 1, 2021 Palmer et al.
20210198749 July 1, 2021 Chang
20210212994 July 15, 2021 Lebo
20210222246 July 22, 2021 Dobak et al.
20210222247 July 22, 2021 Dobak et al.
20210222258 July 22, 2021 Chang
20210246514 August 12, 2021 Chang
20210324480 October 21, 2021 Dobak et al.
20210330245 October 28, 2021 Dobak, III et al.
20210332442 October 28, 2021 Dobak, III et al.
20210345995 November 11, 2021 Dobak, III et al.
20210393542 December 23, 2021 McTavish
20220162682 May 26, 2022 Dobak et al.
20220387005 December 8, 2022 Dobak, III et al.
20230142201 May 11, 2023 Dobak et al.
20230157638 May 25, 2023 David
20240075182 March 7, 2024 Cahill
20240350086 October 24, 2024 David
20240358985 October 31, 2024 Schell
Foreign Patent Documents
2005233547 October 2005 AU
2001161697 June 2001 JP
WO-0010579 March 2000 WO
WO-03001985 January 2003 WO
WO-2005100603 October 2005 WO
WO-2006002433 January 2006 WO
WO-2006039399 April 2006 WO
WO-2007124072 November 2007 WO
WO-2008137772 November 2008 WO
WO-2009140550 November 2009 WO
WO-2010025341 March 2010 WO
WO-2010097773 September 2010 WO
WO-2011039734 April 2011 WO
WO-2012013931 February 2012 WO
WO-2012115885 August 2012 WO
WO-2012125411 September 2012 WO
WO-2012174282 December 2012 WO
WO-2013022995 February 2013 WO
WO-2013033609 March 2013 WO
WO-2013098797 July 2013 WO
WO-2013184905 December 2013 WO
WO-2014028461 February 2014 WO
WO-2014028884 February 2014 WO
WO-2014176446 October 2014 WO
WO-2014210467 December 2014 WO
WO-2016014705 January 2016 WO
WO-2016179043 November 2016 WO
WO-2017165199 September 2017 WO
WO-2018191268 October 2018 WO
WO-2019161126 August 2019 WO
WO-2019183620 September 2019 WO
WO-2019217478 November 2019 WO
WO-2020008192 January 2020 WO
WO-2020035707 February 2020 WO
WO-2020198229 October 2020 WO
WO-2020206085 October 2020 WO
Other references
  • Dermtech sticker collects skin cells so doctors can test for cancer | Fox 10 Azam, YouTube May 21, 2021, viewed online Nov. 18, 2024 at URL: https://www.youtube.com/watch?v=Gch0Vg95Xn0.
  • Albert et al. Years of potential life lost: another indicator of the impact of cutaneous malignant melanoma on society. J Am Acad Dermatol 23(2 Pt 1):308-310 (1990).
  • Bolshakov et al. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Clin Cancer Res. 9(1):228-34 (Jan. 2003).
  • Hayre. Oxytocin Levels Inversely Correlate With Skin Age Score and Solar Damage. J Drugs Dermatol 19(12):1146-1148 (2020).
  • U.S. Appl. No. 14/199,900 Notice of Allowance dated Mar. 30, 2015.
  • U.S. Appl. No. 16/522,291 Office Action dated Dec. 7, 2021.
  • U.S. Appl. No. 16/522,291 Office Action dated Sep. 16, 2021.
  • U.S. Appl. No. 17/002,676 Office Action dated Mar. 13, 2024.
  • U.S. Appl. No. 17/195,541 Office Action dated Sep. 28, 2022.
  • U.S. Appl. No. 17/217,568 Office Action dated Feb. 14, 2023.
  • U.S. Appl. No. 17/217,568 Office Action dated Feb. 15, 2024.
  • U.S. Appl. No. 17/217,568 Office Action dated Sep. 28, 2023.
  • U.S. Appl. No. 17/217,573 Office Action dated Feb. 1, 2023.
  • U.S. Appl. No. 17/217,573 Office Action dated Sep. 6, 2023.
  • U.S. Appl. No. 16/886,611 Office Action dated Mar. 25, 2024.
  • Armstrong et al., The epidemiology of UV induced skin cancer. Journal of Photochemistry and Photobiology B: Biology 63(1-3):8-18 (2001).
  • Baehrecke. miRNAs: micro managers of programmed cell death. Curr Biol 13(12):R473-R475 (2003).
  • Baldi et al. cDNA array technology in melanoma: an overview. J. Cell. Physiol. 196(2):219-223 (2003).
  • Bartel. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2): 281-297 (2004).
  • Becker et al. Mouse models for melanoma: a personal perspective. Experimental Dermatology 19:157-164 (2010).
  • Benson et al. An analysis of select pathogenic messages in lesional and non-lesional psoriatic skin using non-invasive tape harvesting. Journal of Investigative Dermatology 126:2234-2241 (2006).
  • Berardesca et al., Reduced ultraviolet-induced DNA damage and apoptosis in human skin with topical application of a photolyase-containing DNA repair enzyme cream: clues to skin cancer prevention. Molecular Medicine Reports 5(2):570-574 (2012).
  • Booken et al. Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3. Leukemia 22(2):393-9 (2008).
  • Borevitz et al. Large-scale identification of single-feature polymorphisms in complex genomes. Genome Res 13(3):513-523 (2003).
  • Brand et al. Untersuchung menschlicher Hautlymphe: Unterscheiden sich irritative and allergische Kontaktdermatitiden benglich ihres Zytokinmusters? Zeitschrift for Hautkrankheiten, 72:435-440 (1997). (English Abstract).
  • Brehmer-Andersson et al. Tape-Stripping Method for Cytological Diagnosis of Mycosis Fungoides. Acta Derm-Venereol 47:177-180 (1967).
  • Brennecke et al. Bantam encodes a developmentally regulate microRNA that control cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113(1):25-36 (2003).
  • Breslow. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann. Surg. 172:902-908 (1970).
  • Carr et al. Gene-expression profiling in human cutaneous melanoma. Oncogene 22(20):3076-3080 (2003).
  • Cerda et al. Geometry and Physics of Wrinkling. Phys Rev Lett 90(7):074302 (2003).
  • Chen et al. MicroRNAs modulate hematopoietic lineage differentiation. Science 303(5654):83-86 (2004).
  • Childs. Noninvasive gene expression testing in amelanotic melanoma. JAMA Dermatol 154(2):223-224 (2018).
  • Choi et al. Genomic landscape of cutaneous T cell lymphoma. Nat Genet. 47(9):1011-9 (2015).
  • Chuaqui et al. Post-analysis follow-up and validation of microarray experiments. Nature Genetics 32(Supp):509-514 (2002).
  • Ciafre et al. Extensive modulation of a set of MicroRNAs in primary glioblastoma. Biochem Biophys Res Commun. 334(4):1351-1358 (2005).
  • Co-pending U.S. Appl. No. 29/770,783, inventors Dobak; John et al., filed on Feb. 16, 2021.
  • Co-pending U.S. Appl. No. 29/770,784, inventors Dobak; John et al., filed on Feb. 16, 2021.
  • Co-pending U.S. Appl. No. 29/770,785, inventors Dobak; John et al., filed on Feb. 16, 2021.
  • Co-pending U.S. Appl. No. 29/770,786, inventors Dobak; John et al., filed on Feb. 16, 2021.
  • Cummins et al. The colorectal microRNAome. PNAS USA 103(10):3687-3692 (2006).
  • Dalbe et al. Multiscale Stick-Slip Dynamics of Adhesive Tape Peeling. Phys Rev Lett 115(12):128301 (2015).
  • De Zotti et al. Bending to Kinetic Energy Transfer in Adhesive Peel Front Microinstability. Phys Rev Lett 122(6):068005 (2019).
  • Deboyes et al., Reduced number of actinic keratoses with topical application of DNA repair enzyme creams. Journal of drugs in dermatology: JDD 9(12):1519-1521 (2010).
  • Dembinska-Kiec et al. Proangiogenic activity of beta-carotene is coupled with the activation of endothelial cell chemotaxis. Biochimica et Biophysica Acta1740:222-239 (2005).
  • Dulmage et al. Lessons learned from gene expression profiling of cutaneous T-cell lymphoma. Br J Dermatol 169(6):1188-97 (2013).
  • Edelman et al. Analysis of sample set enrichment scores: assaying the enrichment of sets of genes for individual samples in genome-wide expression profiles. Bioinformatics 22(14):e108-116 (2006).
  • Efron et al. Empirical hayes methods and false discovery rates for microarrays. Genet Epidemiol 23(1):70-86 (2002).
  • Elwood et al., Melanoma and sun exposure: an overview of published studies. International Journal of Cancer 73(2):198-203 (1997).
  • Esquela-Kerscher et al., Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6(4):259-69 (2006).
  • Ferris et al. Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month follow-up of negative test results and utility data from a large US registry study. Dermatology Online J 25(5):pii (May 2019).
  • Ferris et al. Noninvasive analysis of high-risk driver mutations and gene expression profiles in primary cutaneous melanoma. J Invest Dermatol 139:1127-1134 (2019).
  • Ferris et al. Real-world performance and utility of a noninvasive gene expression assay to evaluate melanoma risk in pigmented lesions. Melanoma Res 28(5):478-482 (2018).
  • Ferris et al. Utility of a noninvasive 2-gene molecular assay for cutaneous melanoma and effect on the decision to biopsy. JAMA Dermatol 153(7):675-680 (2017).
  • Garcia-Sancha et al. MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma (Review). Int. J. Mol. Sci. 20:2181 (2019).
  • Garofano et al. Comparison of Powerplex® 16 System and Other Multiplex STR Typing Kits on Casework, (Reporto Carabinieri Investigazioni Scientifiche, Parma, Italia.), 2000. Reference available at: http://www. promeea.com/eeneticidproc/ussvmp11proc/default.htm.
  • Garrett et al Tired of the same old grind in the new genomics and proteomics era? Targets Innovations in Genomics & Proteomics 1(5):156-162 (2002).
  • Genecard (www.genecards.org)—Accessed Nov. 11, 2009.
  • Gerami et al. Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma. J Am Acad Dermatol 76(1):114-120.e2 (2017).
  • Gershenwald et al. Gene expression profiling of human cutaneous melanoma: are we there yet? Cancer Biol Ther 3(1):121-123 (2004).
  • Gibson et al. A Novel Method for Real Time Quantitative RT-PCR. Genome Research 6:995-1001 (1996).
  • Gloster et al. The epidemiology of skin cancer. Dermatol Surg. 22(3):217-226 (1996).
  • Gong et al. MiRNA-221 promotes cutaneous squamous cell carcinoma progression by targeting PTEN. Cell Mol Biol Lett. 24:9 (2019).
  • Graengsjoe et al. Different Pathways in Irritant Contact Eczema? Early Differences in the Epidermal Elemental Content and Expression of Cytokines After Application of 2 Different Irritants. Contact Dermatitis 35(6):355-360 (1996).
  • Hammond MicroRNAs as oncogenes. Curr Opin Genet Dev 16(1):4-9 (2006).
  • Haqq et al. The gene expression signatures of melanoma progression. PNAS USA 102(17):6092-6097 (2005).
  • Hirao et al. Elevation of Interleukin 1 Receptor Antagonist in the Stratum Corneum of Sun-Exposed and Ultraviolet B-Irradiated Human Skin. The Journal of Investigative Dermatology 106(5):767-768 (1972).
  • Holleran et al. Regulation of epidermal sphingolipid synthesis by permeability barrier function. J. Lipid Research 32:1151-1158 (1991).
  • Hornberger et al. Clinical and economic implications of a noninvasive molecular pathology assay for early detection of melanoma. JAMA Dermatol 154(9):1-8 (2018).
  • Howie et al. Epidermal keratinocyte production of interferon-gamma immunoreactive protein and mRNA is an early event in allergic contact dermatitis. Journal of Investigative Dermatology 106(6):1218-1223 (1996).
  • Hu et al. MicroRNA-186 promotes cell proliferation and inhibits cell apoptosis in cutaneous squamous cell carcinoma by targeting RETREG1. Expt. Therapeutic Medicine 17:1930-1938 (2019).
  • Instructions for use DermTech adhesive skin biopsy kit. DermTech. Available at http://dermtech.com/wp-content/uploads/2015/10/dermtech-ifu-skin-collection-v7.pdf (Revised data Oct. 2015) (1 pg.).
  • Iorio et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65(16):7065-7070 (2005).
  • Itoh et al. Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs). PLoS One 8(10):e77673 (2013).
  • Jansen et al. Gene expression analysis differentiates melanomas from Spitz nevi. J Drugs Dermatol 17(5):574-576 (2018).
  • Jemal et al. Cancer statistics. CA Cancer J Clin 2003. 53(1):5-26 (2003).
  • Jovanovic. Molecular studies of melanoma. Archive of Oncology13:75-77 (2005).
  • Kalia et al. Homogeneous transport in a heterogeneous membrane: water diffusion across human stratum corneum in vivo. Biophys J 71(5):2692-2700 (1996).
  • Katz et al. Skin surface touch print for diagnosing fungal infections. American Family Physician 31(4):189-194 (1985).
  • Keppler, D. Towards novel anti-cancer strategies based on cystatin function. Cancer Letters 235(2):159-176 (2006).
  • Kim et al. The promise of microarray technology in melanoma care. Cancer Contro. 9(1):49-53 (2002).
  • Koga et al. Genome-wide screen of promoter methylation identifies novel markers in melanoma. Genome Res. 19:1462-1470 (2009).
  • Kohnken et al. MicroRNAs in Cutaneous T-Cell Lymphoma: The Future of Therapy. J Invest Dermatol. 139(3):528-534 (2019).
  • Kong et al. A multivariate approach for integrating genome-wide expression data and biological knowledge. Bioinformatics 22(19):2373-2380 (2006).
  • Koning et al. T Cell Subsets and Cytokines in Allergic and Non-allergic Children. I. Analysis of IL-4 IFN-gamma and IL-13 mRNA Expression and Protein Production. Cytokine 9(6):416-426 (1997).
  • Kricker et al., Sun exposure and non-melanocytic skin cancer. Cancer Causes & Control 5(4):367-392 (1994).
  • Lee et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-854 (1993).
  • Lindahl et al., Quality control by DNA repair. Science 286(5446):1897-1905 (1999).
  • Litvinov et al. Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators. Oncoimmunology 6(5):e1306618 (2017).
  • Litvinov et al., The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-Cell Lymphoma (CTCL). Clin Cancer Res. 21(12):2820-2829 (2015).
  • Liu et al. Inhibition of p38 MAPK signaling augments skin tumorigenesis via NOX2 driven ROS generation. PLoS One 9(5):e97245 (2014).
  • Lucentini, J. Gene Association Studies Typically Wrong. The Scientist, 18(24):20 (2004).
  • Maddox et al. Elevated serum levels in human pregnancy of a molecule immunochemically similar to eosinophil granule major basic protein.J. Exp. Med. 158:1211-1226 (1983).
  • Marin et al., Molluscan shell proteins: primary structure, origin, and evolution. Current Topics in Developmental Biology 80:209-276 (2007).
  • Marttin et al. A Critical Comparison of Methods to Quantify Stratum corneum removed by Tape Stripping. Skin Pharmacology 9:69-77 (1996).
  • McCarty et al. Epidermal hyperplasia overlying human melanoma correlates with tumour depth and angiogenesis. Melanoma Res 13(4):379-387 (2003).
  • Méhul et al. Proteomic analysis of stratum corneum in Cutaneous T-Cell Lymphomas and psoriasis. Exp Dermatol 28(3):317-321 (2019).
  • Michael et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res. 1(12):882-891 (2003).
  • Mitchell et al. Global analysis of cellular transcription following infection with an HIV-based vector. Mol Ther 8(4):674-687 (2003).
  • Morhenn et al. A noninvasive method for quantifying and distinguishing inflammatory skin reactions. Journal of the American Academy of Dermatology 41(5 Pt 1):687-692(1999).
  • Nair et al. Virus-encoded microRNAs: novel regulators of gene expression. Trends Microbiol. 14(4):169-175 (2006).
  • Neagu et al. miRNAs in the Diagnosis and Prognosis of Skin Cancer. Front Cell Dev Biol 8:71 (2020 ).
  • Orro et al., Development of TAP, a non-invasive test for qualitative and quantitative measurements of biomarkers from the skin surface. Biomarker Research 2: (2014).
  • Page et al. The Power Atlas: a power and sample size atlas for microarray experimental design and research. BMC Bioinformatics 7:84 (2006).
  • Paik et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Eng J Med 351(27):2817-2826 (2004).
  • Pang et al. Pathway analysis using random forests classification and regression. Bioinformatic 22(16):2028-2036 (2006).
  • Pavey et al. Microarray expression profiling in melanoma reveals a BRAF mutation signature. Oncogene 23(23):4060-4067 (2004).
  • PCT/US2009/44035 International Search Report and Written Opinion dated Sep. 3, 2009.
  • PCT/US2016/30287 International Search Report and Written Opinion dated Aug. 16, 2016.
  • Perkins et al. Development of a Noninvasive Method for Assessing Human Skin Irritation. The Toxicologist 36(1):365 (1997).
  • Petit-Zeman. MicroRNAs hit the big time. Nat Rev Drug Discov. 5(1):5 (2006).
  • Preston et al., Nonmelanoma cancers of the skin. New England Journal of Medicine 327(23):1649-1662 (1992).
  • Reinhart et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403(6772):901-906 (2000).
  • Rivers et al. Non-invasive gene expression testing to rule out melanoma. Skin Therapy Letter 23(5):1-4 (2018).
  • Rivers et al. Ruling out Melanoma: A practical guide to improving performance through non-invasive gene expression testing. Skin Therapy Letter: Family Practice Edition 14(1):4-6 (2019).
  • Rosenthal et al., Ultraviolet B light induces rapid changes in gene expression as detected by non-invasive, adhesive skin biopsies. [Poster Presentation, Orlando Florida] (Jun. 2019).
  • Seftor et al. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res 61(17):6322-6327 (2001).
  • Shen et al., Epigenetic and genetic dissections of UV-induced global gene dysregulation in skin cells through multi-omics analyses. Scientific Reports 7:42646 (2017).
  • Shen et al., Transcriptome analysis identifies the dysregulation of ultraviolet target genes in human skin cancers. PLoS One 11(9):e0163054 [1-14] (2016).
  • Shin et al. Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome. Blood 110(8):3015-3027 (2007).
  • Siegel et al. Further consideration of the pigmented lesion assay-reply. JAMA Dermatol 155(3):393-394 (2019).
  • Slack et al. MicroRNAs as a potential magic bullet in cancer. Future Oncol. 2(1):73-82 (2006).
  • Slas. From Laboratory to Clinic: Novel Skin Sampling Technique Simplifies Disease Detection. Available at https://www.slas.org/eln/from-laboratory-to-clinic-novel-skin-sampling-technique-simplifies-disease-detection/ (2012) (( pgs).
  • Smyth et al. Statistical issues in eDNA microarray data analysis. Methods Mol Biol 224:111-136 (2003).
  • Stege et al., Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin. Proceedings of the National Academy of Sciences 97(4):1790-1795 (2000).
  • Steinert et al., Small proline-rich proteins are cross-bridging proteins in the cornified cell envelopes of stratified squamous epithelia. Journal of Structural Biology 122(1-2):76-85 (1998).
  • Stoddard et al., Improvement of actinic keratoses using topical DNA repair enzymes: a randomized placebo-controlled trial. Journal of Drugs in Dermatology: JDD 16(10):1030-1034 (2017).
  • Stolz et al. Semiquantitative analysis of histologic criteria in thin malignant melanomas. J Am Acad Dermato. 20(6):1115-1120 (1989).
  • Stuart et al. In silico dissection of cell-type—associated patterns of gene expression in prostate cancer. PNAS USA 101(2):615-620 (2004).
  • Su et al. Identification of tumor-suppressor genes using human melanoma cell lines UACC903, UACC903(+6), and SRS3 by comparison of expression profiles. Mol Carcinog 28(2):119-127 (2000).
  • Tagawa. A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia. 19(11):2013-2016 (2005).
  • Takashi et al. Novel melanoma antigen, FCRL/FREB, identified by cDNA profile comparison using DNA chip Are immunogenic in multiple melanoma patients. International Journal of Cancer 114(2):283-290 (2005).
  • Thoma. Light and dark in chromatin repair: repair of UV-induced DNA lesions by photolyase and nucleotide excision repair. The EMBO Journal 18(23):6585-6598 (1999).
  • Thoroddsen et al. Stick-slip substructure in rapid tape peeling. Phys Rev Lett 82(4 Pt 2):046107 (2010).
  • Tibshirani et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression. PNAS USA 99(10):6567-6572 (2002).
  • Torabian et al. Biomarkers for melanoma. Current Opinion in Oncology 17:167-171 (2005).
  • Torres et al. MicroRNA Ratios Distinguish Melanomas from Nevi. J Invest Dermatol . 140(1):164-173.e7 (2020).
  • U.S. Appl. No. 12/991,685 Office Action dated Mar. 13, 2013.
  • U.S. Appl. No. 12/991,685 Office Action dated Nov. 4, 2013.
  • U.S. Appl. No. 14/172,784 Office Action dated Apr. 23, 2015.
  • U.S. Appl. No. 14/199,900 Office Action dated Dec. 10, 2014.
  • U.S. Appl. No. 14/199,900 Pending Claims.
  • U.S. Appl. No. 14/832,966 Office Action dated Apr. 12, 2018.
  • U.S. Appl. No. 14/832,966 Office Action dated Aug. 10, 2017.
  • U.S. Appl. No. 14/832,966 Office Action dated Nov. 16, 2018.
  • U.S. Appl. No. 16/522,291 Office Action dated Apr. 28, 2021.
  • U.S. Appl. No. 16/522,291 Office Action dated Jan. 7, 2021.
  • Vaqué et al. PLCG1 mutations in cutaneous T-cell lymphomas. Blood 123(13):2034-43 (2014).
  • Volinia et al. A microRNA expression signature of human solid tumors defines cancer gene targets. PNAS USA 103(7):2257-2261 (2006).
  • Wachsman et al. Differentiation of melanoma from dysplastic nevi in suspicious pigmented skin lesions by non-invasive tape stripping. Journal of Dermatology 127(Supp 1s):S145 (2007).
  • Wachsman et al. Non-invasive genomic detection of melanoma, British Journal of Dermatology 164:797-806 (2011).
  • Wang et al. Why minimally invasive skin sampling techniques? A bright scientific future. Cutan Ocul Toxicol 30(1):1-6 (2011).
  • Washington Report: Skin Tape Stripping Method for Generic Dermatologic Drug Approval Remains in Question, http://www.aadassociation.org/old/washReports/dec99_washrep.html (1999).
  • Weigand et al. Removal of Stratum Corneum in Vivo: An Improvement of the Cellophane Tape Strapping Technique. The Journal of Investigative Dermatology 60(2):84-87 (1973).
  • Wolf et al., Topical treatment with liposomes containing T4 endonuclease V protects human skin in vivo from ultraviolet-induced upregulation of interleukin-10 and tumor necrosis factor-α. Journal of Investigative Dermatology 114.1:149-156 (2000).
  • Wolyn et al. Light-response quantitative trait loci identified with composite interval and extreme array mapping in Arabidopsis thaliana. Genetics 167(2):907-917 (2004).
  • Wong et al. Analysis of RNA recovery and gene expression in the epidermis using non-invasive tape stripping. J Dermatol Science 44:81-92 (2006).
  • Wong et al. Use of RT-PCR and DNA Microarrays to Characterize RNA Recovered by Non-Invasive Tape Harvesting of Normal and Inflamed Skin. Journal of Investigative Dermatology 123(1):159-167 (2004).
  • Wu et al. Preprocessing of oligonucleotide array data. Nat Biotechnol 22(6):656-658; author reply 658 (2004).
  • Wu et al. Stochastic models inspired by hybridization theory for short oligonucleotide arrays. J Comput Bio. 12(6):882-893 (2005).
  • Yanaihara et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 9(3):189-198 (2006).
  • Yao et al. An adhesive patch-based skin biopsy device for molecular diagnostics and skin microbiome studies. J Drugs Dermatol 16:979-986 (2017).
  • Yao et al. Analytical Characteristics of a Noninvasive Gene Expression Assay for Pigmented Skin Lesions. Assay Drug Del Technol 14(6):355-363 (2016).
  • Yarosh et al., Pyrimidine dimer removal enhanced by DNA repair liposomes reduces the incidence of UV skin cancer in mice. Cancer Research 52(15):4227-4231 (1992).
  • Yarosh et al., Xeroderma pigmentosum study group. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. The Lancet 357(9260):926-929 (2001).
  • Zou et al., Strand opening by the UvrA2B complex allows dynamic recognition of DNA damage. The EMBO Journal 18(17):4889-4901 (1999).
  • Co-pending U.S. Appl. No. 29/866,396, inventor Gina Makris, filed Sep. 9, 2022.
  • Co-pending U.S. Appl. No. 29/866,397, inventor Gina Makris, filed Sep. 9, 2022.
  • Co-pending U.S. Appl. No. 29/866,398, inventor Gina Makris, filed Sep. 9, 2022.
  • Co-pending U.S. Appl. No. 29/866,399, inventor Gina Makris, filed Sep. 9, 2022.
  • Anderson et al.; “Variations in Physical Dimensions and Chemical Composition of Human Stratum Corneum”; The Journal of Investigative Dermatology; c. 1973; vol. 61; pp. 30-32.
  • Final Office Action issued Dec. 2, 2024 in corresponding U.S. Appl. No. 17/002,676.
  • Non-Final Office Action issued Feb. 24, 2025 in corresponding U.S. Appl. No. 17/183,589.
  • International Preliminary Report on Patentability issued in corresponding International Application No. PCT/US2016/030287 mailed Nov. 7, 2017.
Patent History
Patent number: D1097166
Type: Grant
Filed: Jun 24, 2021
Date of Patent: Oct 7, 2025
Assignee: DERMTECH, LLC (San Diego, CA)
Inventor: John Dobak, III (La Jolla, CA)
Primary Examiner: Jennifer L Watkins
Application Number: 29/796,477
Classifications
Current U.S. Class: Bandage For Protection Or Treatment (53) (D24/189)